GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,818,000 | -43.6% | 59,794 | -19.7% | 0.72% | -42.0% |
Q2 2022 | $3,223,000 | -1.4% | 74,440 | -0.0% | 1.25% | +12.1% |
Q1 2022 | $3,268,000 | +1.0% | 74,455 | -0.3% | 1.11% | +1.5% |
Q4 2021 | $3,237,000 | +12.9% | 74,644 | -0.7% | 1.10% | +5.6% |
Q3 2021 | $2,866,000 | -5.0% | 75,163 | +0.8% | 1.04% | -4.4% |
Q2 2021 | $3,018,000 | +13.9% | 74,600 | +0.5% | 1.09% | +4.5% |
Q1 2021 | $2,649,000 | -7.1% | 74,215 | -1.7% | 1.04% | -16.1% |
Q4 2020 | $2,850,000 | -0.6% | 75,521 | -0.9% | 1.24% | -12.6% |
Q3 2020 | $2,868,000 | -6.0% | 76,207 | +1.9% | 1.42% | -11.3% |
Q2 2020 | $3,050,000 | +10.2% | 74,778 | +2.4% | 1.60% | -5.4% |
Q1 2020 | $2,768,000 | -17.8% | 73,057 | +0.9% | 1.69% | +3.9% |
Q4 2019 | $3,368,000 | +10.6% | 72,432 | -0.1% | 1.63% | +2.0% |
Q3 2019 | $3,045,000 | +2.3% | 72,507 | +0.7% | 1.59% | +4.4% |
Q2 2019 | $2,976,000 | +1.6% | 72,000 | +2.7% | 1.53% | -0.6% |
Q1 2019 | $2,929,000 | +9.0% | 70,092 | +1.6% | 1.54% | +2.0% |
Q4 2018 | $2,688,000 | -0.8% | 68,976 | +2.6% | 1.51% | +3.1% |
Q2 2018 | $2,710,000 | – | 67,227 | – | 1.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |